Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates in two segments, Home & Community Services and Episodes of Care Services. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers primarily under the Medicare Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. Its customers include health plans, governments, employers, health systems, and physician groups. The company was founded in 2017 and is headquartered in Dallas, Texas with additional offices in Austin, New York, Norwalk, and Rapid City.
IPO Year: 2021
Exchange: NYSE
Website: signifyhealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/31/2022 | $35.00 | Buy | BTIG Research |
| 7/29/2022 | $18.00 | Sector Perform | RBC Capital Mkts |
| 5/16/2022 | $19.00 → $16.00 | Neutral → Outperform | Robert W. Baird |
| 3/30/2022 | $36.00 | Buy | Guggenheim |
| 3/9/2022 | $27.00 → $18.00 | Market Perform | Cowen & Co. |
| 3/9/2022 | $20.00 → $21.00 | Neutral → Buy | UBS |
| 3/7/2022 | $34.00 → $27.00 | Overweight | Piper Sandler |
| 2/11/2022 | $20.00 | Buy | Goldman Sachs |
| 9/23/2021 | $30.00 → $24.00 | Outperform → Neutral | Robert W. Baird |
| 9/23/2021 | $30.00 → $24.00 | Outperform → Neutral | Baird |
SC 13G/A - Signify Health, Inc. (0001828182) (Subject)
SC 13G - Signify Health, Inc. (0001828182) (Subject)
SC 13G/A - Signify Health, Inc. (0001828182) (Subject)
SC 13G - Signify Health, Inc. (0001828182) (Subject)
4 - Signify Health, Inc. (0001828182) (Issuer)
4 - Signify Health, Inc. (0001828182) (Issuer)
4 - Signify Health, Inc. (0001828182) (Issuer)
4 - Signify Health, Inc. (0001828182) (Issuer)
4 - Signify Health, Inc. (0001828182) (Issuer)
4 - Signify Health, Inc. (0001828182) (Issuer)
4 - Signify Health, Inc. (0001828182) (Issuer)
4 - Signify Health, Inc. (0001828182) (Issuer)
4 - Signify Health, Inc. (0001828182) (Issuer)
4 - Signify Health, Inc. (0001828182) (Issuer)
BTIG Research initiated coverage of Signify Health with a rating of Buy and set a new price target of $35.00
RBC Capital Mkts initiated coverage of Signify Health with a rating of Sector Perform and set a new price target of $18.00
Robert W. Baird upgraded Signify Health from Neutral to Outperform and set a new price target of $16.00 from $19.00 previously
Guggenheim initiated coverage of Signify Health with a rating of Buy and set a new price target of $36.00
Cowen & Co. reiterated coverage of Signify Health with a rating of Market Perform and set a new price target of $18.00 from $27.00 previously
UBS upgraded Signify Health from Neutral to Buy and set a new price target of $21.00 from $20.00 previously
Piper Sandler reiterated coverage of Signify Health with a rating of Overweight and set a new price target of $27.00 from $34.00 previously
Goldman Sachs initiated coverage of Signify Health with a rating of Buy and set a new price target of $20.00
Robert W. Baird downgraded Signify Health from Outperform to Neutral and set a new price target of $24.00 from $30.00 previously
Baird downgraded Signify Health from Outperform to Neutral and set a new price target of $24.00 from $30.00 previously
Advances long-term strategy by providing platform for growth in value-based care WOONSOCKET, R.I., DALLAS and NEW YORK, Sept. 5, 2022 /PRNewswire/ -- CVS Health® (NYSE:CVS) and Signify Health (NYSE:SGFY) ("Signify") have entered into a definitive agreement under which CVS Health will acquire Signify Health for $30.50 per share in cash, representing a total transaction value of approximately $8 billion. Signify Health is a leader in Health Risk Assessments, value-based care and provider enablement. With a network of more than 10,000 clinicians across all 50 states and a nationw
Financial Highlights Second Quarter 2022: Revenue of $246.2 million, an increase of 16% from second quarter 2021 GAAP net loss of $490.0 million, which includes a $519.9 million loss on impairment related to our decision to exit the Episodes of Care Services segment. Non-GAAP adjusted EBITDA1 of $62.6 million, an increase of 15% from second quarter 2021 2022 Guidance: Signify Health is providing guidance for full year 2022 as follows: Home & Community Services (HCS) segment revenue in the range of $800 million to $810 million; Revenue from the Caravan Health acquisition in the range of $45 million to $48 million; Adjusted EBITDA margin1 for HCS and Caravan Health of 29% to 3
Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, announced that it will release its financial results for the second quarter 2022 after the market closes on Wednesday, August 3, 2022, and will hold a conference call at 8:30am ET on Thursday, August 4, 2022 to discuss the results. Pre-registration is required for participation in the conference call. Please follow the link below to pre-register. After registering, you will be provided with your access details via email. http://www.incommuk.com/customers/signifyhealthquartertwo2022 A webcast of the conference call will also be available
Changes expected to have positive impact on 2023 earnings Company ending its participation in the BPCI-A program to focus on supporting future growth Signify Health, Inc. (NYSE:SGFY) today announced that it is winding down its Episodes of Care Services (ECS) segment in order to focus on its fast-growing and profitable Home and Community Services (HCS) business and recent Caravan Health acquisition. The Company is exiting CMS' Bundled Payments for Care Improvement-Advanced (BPCI-A) program in light of the newly released CMS retrospective trend calculations that lowered target prices for episodes, thereby reducing the opportunity for savings. This strategic and timely decision allows the C
Financial Highlights First Quarter 2022: First quarter revenue of $216.5 million, an increase of 20% from first quarter 2021 GAAP net loss of $16.3 million improved compared to net loss of $51.7 million in first quarter 2021 Non-GAAP adjusted EBITDA1 of $45.0 million, an increase of 31% from first quarter 2021 2022 Guidance: Signify Health maintains estimates for full year 2022 results as follows: Total revenue in the range of $948 million to $971 million; and Total adjusted EBITDA1 in the range of $212 million to $222 million Signify Health, Inc. (NYSE:SGFY), a leading healthcare platform that leverages advanced analytics, technology and nationwide healthcare networks to
Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, announced that it will release its financial results for the first quarter 2022 after the market closes on Wednesday, May 4, 2022, and will hold a conference call at 8:30am ET on Thursday, May 5, 2022 to discuss the results. Pre-registration is required for participation in the conference call. Please follow the link below to pre-register. After registering, you will be provided with your access details via email. http://www.incommuk.com/customers/signifyhealthquarterone2022 A webcast of the conference call will also be available live o
Company to harness combined capabilities to accelerate adoption of advanced alternative payment models, supporting the Centers for Medicare and Medicaid's critical imperatives to improve health equity and have everyone in Medicare fee-for-service aligned to an accountable entity by 2030 Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform that leverages advanced analytics, technology and nationwide healthcare provider networks, today announced it has completed the acquisition of Caravan Health, a leader in enabling accountable care organizations (ACOs) to excel in population health management and value-based payment programs. The combination creates one of the large
Combined company will create one of the largest networks of at-risk providers, improving patient outcomes while lowering costs across the care continuum Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform that leverages advanced analytics, technology and nationwide healthcare provider networks, today announced it has signed an agreement to acquire Caravan Health, a leader in enabling accountable care organizations (ACOs) to excel in population health management and value-based payment programs, for an initial purchase price of approximately $250 million in a combination of cash and Signify Health common stock. The transaction also includes contingent additional paym
Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, announced that it will release its financial results for the fourth quarter 2021 after the market closes on Wednesday, March 2, 2022, and will hold a conference call at 8:30am ET on Thursday, March 3, 2022 to discuss the results. Pre-registration is required for participation in the conference call. Please follow the link below to pre-register. After registering, you will be provided with your access details via email. http://www.incommuk.com/customers/signifyhealthquarterfour2021 A webcast of the conference call will also be available
Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, announced that it will release its financial results for the third quarter 2021 after the market closes on Tuesday, November 9, 2021, and will hold a conference call at 8:30am ET on Wednesday, November 10, 2021, to discuss the results. Pre-registration is required for participation in the conference call. Please follow the link below to pre-register. After registering, you will be provided with your access details via email. www.incommuk.com/customers/signifyhealthquarterthree2021 A webcast of the conference call will also be available
15-12G - Signify Health, Inc. (0001828182) (Filer)
25-NSE - Signify Health, Inc. (0001828182) (Subject)
S-8 POS - Signify Health, Inc. (0001828182) (Filer)
8-K - Signify Health, Inc. (0001828182) (Filer)
10-K - Signify Health, Inc. (0001828182) (Filer)
10-Q - Signify Health, Inc. (0001828182) (Filer)
8-K - Signify Health, Inc. (0001828182) (Filer)
8-K - Signify Health, Inc. (0001828182) (Filer)
8-K - Signify Health, Inc. (0001828182) (Filer)
DEFM14A - Signify Health, Inc. (0001828182) (Filer)
A 30+ year industry veteran from Signify Health and Match.com, Shane joins to scale Virta's technology platform amid triple-digit year-over-year growth Today, diabetes reversal leader Virta Health announced the addition of Shane Henderson as Chief Technology Officer (CTO). With over three decades of experience at companies like Signify Health and Match.com, Shane joins to scale Virta's technology through continued triple-digit growth and surging demand for its innovative approach to treating metabolic diseases like type 2 diabetes, prediabetes, and obesity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220510006160/en/As CTO, S
WALTHAM, Mass., Sept. 1, 2021 /PRNewswire/ -- GoodCell, a medically-actionable health technology service to proactively identify, track and address health risks, today announces it has appointed Chris Garcia as its new Chief Executive Officer and member of the Board of Directors, effective immediately. In his new role, Mr. Garcia will work to scale GoodCell's commercial strategy, while founder Trevor Perry will assume the title of President and remain as a director of the company. "The Board of Directors and I are excited to have Chris lead our organization into its next chapter of development," said Mr. Perry. "Chris' addition validates the value of what we have built at GoodCell to date a
Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform that leverages advanced analytics, technology and nationwide healthcare provider networks, today announced the appointment of Arnold Goldberg as an independent member of its board of directors, serving on the audit committee. Most recently serving as Senior Vice President, Chief Product Architect and Senior Technologist at PayPal, Mr. Goldberg brings deep knowledge of platform architecture and product strategy to Signify Health, as well as valuable experience leading and scaling teams of technologists for some of the biggest and most groundbreaking technology companies of the past two decades. This press release fea
Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform that leverages advanced analytics, technology and nationwide healthcare provider networks, today announced the appointment of Sam Pettijohn as Chief Growth Officer and Erin Kelly as Chief Compliance Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210719005208/en/Sam Pettijohn joins Signify Health as Chief Growth Officer (Photo: Business Wire) As Chief Growth Officer, Sam Pettijohn will lead Signify Health's continued growth as the Company expands its suite of offerings and its market presence across the public and private healthcare markets. In ad
Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform that leverages advanced analytics, technology and nationwide healthcare provider networks, today announced the appointment of Susan Yun as Chief People Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210602006026/en/Susan Yun joins Signify Health as Chief People Officer (Photo: Business Wire) Susan brings to Signify Health nearly 30 years of experience in strategic HR leadership in mid-size and large companies, including Information Builders, the Juvenile Diabetes Research Foundation and General Electric Corporation. "Susan's expertise in transfo
Healthcare Veteran and General Counsel Join Company to Support Growing Momentum K Health, the 24/7 primary care system, announced today the appointment of Vivian Riefberg to its board. Riefberg is a board member at Johns Hopkins Medicine, PBS, and Signify Health (NYSE:SGFY) and the former co-leader of the health services practice at McKinsey & Company. K Health also announced that Chen Yehudai, former Vice President and General Counsel at Teva Pharmaceuticals (NYSE:TEVA), has joined its executive team as the company's first General Counsel. With over 4 million users, K Health's base continues to grow, with demand increasing rapidly since the start of the pandemic. Riefberg and Yehudai wil
Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform that leverages advanced analytics, technology and nationwide healthcare provider networks, today announced the appointment of Tracey Scraba as Senior Vice President, Deputy General Counsel and Lisa Wagamon, Senior Vice President, Network Development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210518005332/en/Tracey Scraba joins Signify Health as Senior Vice President, Deputy General Counsel (Photo: Business Wire) "We are delighted to welcome Tracey and Lisa to Signify Health. Their expertise and leadership will help us continue to build our value-base
BOSTON, May 17, 2021 /PRNewswire/ -- Patient Discovery Solutions, a leader in patient-provider engagement technologies which harness the power of real-world data to achieve better health outcomes, today announced the appointment of Theresa West to the position of Chief Commercial Officer. In this newly created role, Ms. West will lead all aspects of Patient Discovery's commercialization efforts, leveraging more than 20 years of healthcare technology experience, encompassing sales, marketing and new product launches. "We are extremely pleased to welcome Theresa to Patient Disc
Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform that leverages advanced analytics, technology and nationwide healthcare provider networks, today announced the appointment of Heather Dixon, CPA, as an independent member of its board of directors, serving on the audit committee. As Senior Vice President, Global Controller and Chief Accounting Officer at Walgreens Boots Alliance, Dixon has deep insight into the strategic priorities of healthcare payors, as well as a strong track record of leadership in finance for public companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210428006034/en/Heather Dix
On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners named UnitedHealth Group Incorporated (NYSE:UNH) as his final trade. Raymond James recently upgraded UnitedHealth Group from Outperform to Strong Buy and raised the price target from $615 to $630. Joshua Brown of Ritholtz Wealth Management said there's a "breakout in progress" on Oracle Corporation (NYSE:ORCL). Oracle announced plans to open a second cloud region in Singapore. Don’t forget to check out our premarket coverage here Jim Lebenthal of Cerity Partners picked CVS Health Corporation (NYSE:CVS). CVS Health said it expects to close on the acquisition of Signify Health Inc (NYSE:SGFY)
Signify Health Inc (NYSE:SGFY) shares are trading higher after CVS Health Corp (NYSE:CVS) said it expects to close on the acquisition of Signify on or around March 29. What Else? The companies entered into a definitive agreement in September 2022 under which CVS Health announced it would acquire Signify Health for $30.50 per share in cash for a total transaction value of approximately $8 billion. See Also: Why First Republic Bank Stock Is Popping Off Upon completion of the acquisition, Signify Health will continue to operate as a payor-agnostic business as part of CVS Health. According to data from Benzinga Pro, SGFY has a 52-week high of $29.88 and a 52-week low of $10.70.
The companies entered into a definitive agreement in September 2022 under which CVS Health announced it would acquire Signify Health for $30.50 per share in cash for a total transaction value of approximately $8 billion. Upon completion of the acquisition, Signify Health will continue to operate as a payor-agnostic business as part of CVS Health.
Cardinal Health (NYSE:CAH) today announced its collaboration with Signify Health (NYSE:SGFY) to offer in-home clinical and medication management services through its Outcomes™ business. This collaboration will help reduce costs and eliminate gaps in care for more than 2.3 million members nationwide to support their treatment journey from prescription to pharmacy to home. Studies have shown that many members do not take their medications as prescribed. Bringing together Signify Health's1 mobile network of 11,000+ credentialed clinicians with Outcomes' industry leading OutcomesOne™ clinical care platform and omnichannel network of pharmacies and payers, this collaboration will help to addres
Ardent transitions from the BPCI-A program to join a 2023 Signify Health-supported ACO designed to achieve superior patient outcomes and success in managing total costs Signify Health, Inc. (NYSE:SGFY), a leading healthcare platform that leverages advanced analytics, technology and nationwide healthcare networks to create and power value-based payment programs, today announced an expansion of its relationship with Ardent Health Services, a premier provider of healthcare services with more than 200 sites of care across six states. A former participant in the Center for Medicare and Medicaid Innovation's Bundled Payments for Care Improvement-Advanced (BPCI-A) program, Ardent will join a 2023
Cathie Wood-led ARK Investment Management bought over 330,000 shares of clinical-stage biotechnology company Verve Therapeutics Inc (NASDAQ:VERV) at an estimated valuation of over $6.9 million, based on Tuesday’s closing price. The purchase was done through the flagship ARK Innovation ETF (NYSE: ARKK) and the ARK Genomic Revolution ETF (NYSE:ARKG). The company's stock has lost over 4.5% in five days. On Monday, Verve announced it received a clinical hold letter from the FDA that outlined the information required to resolve the clinical hold on Verve-101. Also Read: Best Penny Stocks According to the company, Verve-101 is a novel, investigational gene editing medicine designed to be a sing
Walgreens Boots Alliance Inc (NASDAQ:WBA) VillageMD is weighing a merger with Warburg Pincus-backed Summit Health. The deal of VillageMD acquiring Summit would value the combined entity at between $5 billion to $10 billion. An agreement could be reached in the coming weeks, though talks could still fall apart, Bloomberg reported. The talks come as Walgreens rivals, including CVS Health Corp (NYSE:CVS) and Amazon.com Inc (NASDAQ:AMZN), push deeper into primary health care through significant acquisitions, including $8 billion for Signify Health Inc (NYSE:SGFY) and around $4 billion for 1life Healthcare Inc, respectively. In September, CVS Health showed interest in buying Cano Health Inc
-8-K
Cathie Wood-led Ark Investment Management on Wednesday sold 96,746 shares of Signify Health Inc. (NYSE: SGFY), estimated to be valued at around $2.8 million. The firm sold 38,669 shares via its flagship ARK Innovation ETF (NYSE: ARKK) exchange-traded fund and 58,007 via the ARK Genomic Revolution ETF (BATS: ARKG). Signify shares closed 0.17% higher at $29.15 on Wednesday, according to data from Benzinga Pro. Wood began selling Signify shares when they saw a major spike on Aug. 22 after reports said Amazon.com Inc. (NASDAQ: AMZN) may be interested in acquiring the healthcare company. See Also: Best Healthcare Stocks Right Now
WOONSOCKET, R.I. and DALLAS and NEW YORK, March 27, 2023 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced it expects to complete its acquisition of Signify Health (NYSE:SGFY) on or around March 29, 2023, subject to the satisfaction or waiver of the remaining customary closing conditions set forth in the merger agreement. The companies entered into a definitive agreement in September 2022 under which CVS Health announced it would acquire Signify Health for $30.50 per share in cash for a total transaction value of approximately $8 billion. Upon completion of the acquisitio
DUBLIN, Ohio, March 6, 2023 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced its collaboration with Signify Health (NYSE:SGFY) to offer in-home clinical and medication management services through its Outcomes™ business. This collaboration will help reduce costs and eliminate gaps in care for more than 2.3 million members nationwide to support their treatment journey from prescription to pharmacy to home. Studies have shown that many members do not take their medications as prescribed. Bringing together Signify Health's1 mobile network of 11,000+ credentialed clinicia
Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced that Heather Dixon, CPA, has been appointed to the Company's Board of Directors as an independent board member, effective March 1, 2023. She fills the seat previously held by Steven Geringer and will serve as a member of the Audit Committee. Dixon currently serves as Chief Financial Officer of Everside Health, one of the nation's largest direct primary care providers. In this role, she provides financial oversight and strategic direction with a focus on growth and innovation within the direct primary care space. Prior to joining Everside, she was the Senior Vice President, Global Controller and Chie
Through this new program, Signify Health aims to create a sustainable pathway for rural providers and FQHCs to participate in Medicare value-based payment programs Signify Health, Inc. (NYSE:SGFY), a leading healthcare platform that leverages advanced analytics, technology and nationwide healthcare networks to create and power value-based payment programs, today announced the Company's intention to participate in the Centers for Medicare and Medicaid Services (CMS) Advance Investment Payments (AIP) incentive program to support providers in rural and underserved communities. Americans living in rural communities have a shorter life expectancy than their urban counterparts. A recent report
Prospect's facilities, Eastern Connecticut Health Network (ECHN) and Waterbury HEALTH, and affiliated providers in Connecticut to participate in a Signify Health-supported ACO designed to achieve superior patient outcomes and success in managing total costs Signify Health, Inc (NYSE:SGFY), a leading healthcare platform that leverages advanced analytics, technology and nationwide healthcare networks to create and power value-based payment programs, today announced a new collaboration with Prospect Medical Holdings, Inc., a growing healthcare services company with 16 hospitals serving underserved communities in four states. In 2023, Prospect's Waterbury HEALTH and Eastern Connecticut Health
Ardent transitions from the BPCI-A program to join a 2023 Signify Health-supported ACO designed to achieve superior patient outcomes and success in managing total costs Signify Health, Inc. (NYSE:SGFY), a leading healthcare platform that leverages advanced analytics, technology and nationwide healthcare networks to create and power value-based payment programs, today announced an expansion of its relationship with Ardent Health Services, a premier provider of healthcare services with more than 200 sites of care across six states. A former participant in the Center for Medicare and Medicaid Innovation's Bundled Payments for Care Improvement-Advanced (BPCI-A) program, Ardent will join a 2023
The expanded offering aims to increase access to screenings and preventive care to address leading causes of morbidity and mortality among Medicare members Signify Health (NYSE:SGFY), a leading healthcare platform that leverages advanced analytics, technology and nationwide healthcare networks to create and power value-based payment programs, today announced the expansion of its in-home Diagnostic and Preventive Services offering for Medicare Advantage and Medicaid plan members. The offering supports the early detection, diagnosis, and management of some of the leading causes of morbidity and mortality among Medicare members, including chronic obstructive pulmonary disease (COPD), periphe
Certification supports Signify Health's expanded in-home diagnostic and preventive screenings for at-risk health plan members Signify Health (NYSE:SGFY), a leading healthcare platform that leverages advanced analytics, technology, and nationwide healthcare networks to create and power value-based payment programs, has again achieved the National Committee for Quality Assurance (NCQA) certification for the Healthcare Effectiveness Data and Information Set (HEDIS®). This is the second year in which the Company has received this certification. NCQA provides accreditations and certifications to evaluate a wide range of organizations across the healthcare system. More than 90 percent of health
Advances long-term strategy by providing platform for growth in value-based care WOONSOCKET, R.I., DALLAS and NEW YORK, Sept. 5, 2022 /PRNewswire/ -- CVS Health® (NYSE:CVS) and Signify Health (NYSE:SGFY) ("Signify") have entered into a definitive agreement under which CVS Health will acquire Signify Health for $30.50 per share in cash, representing a total transaction value of approximately $8 billion. Signify Health is a leader in Health Risk Assessments, value-based care and provider enablement. With a network of more than 10,000 clinicians across all 50 states and a nationw
Signify's provider partners saved more than $138 million in 2021, and all Collaborative ACOs earned 100 percent on their Merit-Based Incentive Payment System scores Signify achieves record ACO sales for 2023, Collaborative ACOs to reach over 700,000 attributed lives in 2023 Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform enabled by advanced analytics, technology, and nationwide healthcare networks, today announced that its collaborative accountable care organizations (ACOs) generated more than $138 million in gross savings in 2021. As a result of their strong performance in the Medicare Shared Savings Program, community hospitals and their affiliated physician